EGFR/HER2

Inhibitory Selectivity
Catalog No.Inhibitor Name EGFR/ErbB1HER2/ErbB2ErbB3ErbB4Other
A10362Erlotinib HCl
****
A10422Gefitinib
**
A10514Lapatinib Ditosylate
**
**
*
c-Src
A10141Afatinib
****
**
A10638Neratinib
*
*
KDR,Src
A10211Canertinib
****
***
A11752Lapatinib
**
**
*
c-Src
A10047AG-490
*
*
JAK2
A10242CP-724714
**
A11051Dacomitinib
***
*
*
A10991WZ4002
****
***
A10116Sapitinib
***
***
HDAC,HDAC1,HDAC6
A10246CUDC-101
***
**
A11022AG-1478
***
A10702PD153035 HCl
****
Src,MEK/ERK,Raf
A10706Pelitinib
*
*
c-Abl,FLT1,c-Fms
A10043AEE788
****
***
*
MEK,LCK,VEGFR2
A11209AC480
**
*
*
A10678OSI-420
****
A10990WZ3146
****
A11155AST-1306
****
***
****
A13028Rociletinib
**
A11158Varlitinib
***
****
A13825Icotinib
***
MEK1,Aurora B,LCK
A11236TAK-285
**
**
*
Src,VEGFR,JAK3
A14049WHI-P154
***
A12725PD168393
****
A13755CNX-2006
**
PDGFR
A11949Tyrphostin 9
*
A15940AG-18
*
A15551AZD3759
****
A14985Afatinib Dimaleate
****
**
A13146CL-387785
****
A13044Poziotinib
***
***
**
A13681Osimertinib
**
BLK,ACK1,BRK
A15516AZ5104
****
***
A10992WZ8040
topo II
A10426Genistein
A12448Butein
mTOR
A10210Chrysophanic Acid
A10053Tyrphostin AG 879
*
Trk
A10286Daphnetin
*
PKC, PKA
A11027Irbinitinib (ARRY-380, ONT-380)
****
A11028AV-412
***
*
A11334BIBX 1382
****
*
A12867CGP-52411
*
A13588Tyrphostin AG 183
*
A15509WHI-P180
*
Cdk2
A10612Mubritinib (TAK 165)
****
A16413ARRY-380 (Irbinitinib)
****

Notes:
1.Hover mouse over " * " to view the IC50 value.(A few compounds have proven potency but without published IC50 data.)
2.For more details about the compound, click on the product name of your interest.
3.The higher the number of " * " is, the more potent the inhibitor or activator is.
4."" refers to compounds which do inhibitory effects on the related isoform, but without specific value.

产品 1 到 50 共 106个

每页
页面:
  1. 1
  2. 2
  3. 3

设置降序顺序
  1. Avitinib (AC0010)

    Catalog No. A16826
    Quick View
    irreversible EGFR 抑制剂
    Avitinib (AC0010)是一种基于吡咯并嘧啶的不可逆EGFR抑制剂,对EGFR L858R/T790M双重突变具有突变选择性,IC50值为0.18 nM,效力比野生型EGFR(IC50值为7.68 nM)高近43倍。它具有可比的抗肿瘤活性和耐受的毒性。 了解更多
  2. Lazertinib (YH25448,GNS-1480)

    Catalog No. A16827
    Quick View
    EGFR 抑制剂
    Lazertinib (YH25448,GNS-1480)是一种有效的,高度突变选择性和不可逆的EGFR-TKI,对于Del19/T790M,L858R/T790M,Del19,Del19,IC50值分别为1.7 nM,2 nM,5 nM,20.6 nM和76 nM。L85R和野生型EGFR分别显示出更高的IC50值,即抗药性ErbB2和ErbB4。 了解更多
  3. Tyrphostin AG-528

    Catalog No. A17072
    Quick View
    EGFR 抑制剂
    Tyrphostin AG-528,也称为Tyrphostin B66,是EGFR蛋白酪氨酸激酶抑制剂。 了解更多
  4. Pyrotinib Racemate

    Catalog No. A17068
    Quick View
    EGFR/HER2 dual 抑制剂
    Pyrotinib Racemate是吡罗替尼的外消旋体。吡罗替尼是一种有效的选择性EGFR/HER2双重抑制剂。 了解更多
    • 最新产品

    AG-494

    Catalog No. A17142
    Quick View
    EGFR 抑制剂
    AG-494是表皮生长因子受体激酶的抑制剂,在HT-22细胞中的IC50值为1μM。 了解更多
  5. Lavendustin A

    Catalog No. A17119
    Quick View
    EGFR 抑制剂
    Lavendustin A是表皮生长因子(EGF)受体相关酪氨酸激酶的选择性抑制剂,IC50值为11 nM。 了解更多
  6. AG-99

    Catalog No. A17123
    Quick View
    EGFR 抑制剂
    AG-99是一种表皮生长因子受体(EGFR)激酶抑制剂,IC50值为10μM。 了解更多
  7. AG 555

    Catalog No. A18337
    Quick View
    EGFR 抑制剂
    AG555 is a potent epidermal growth factor receptor (EGFR) kinase inhibitor. 了解更多
  8. RG14620

    Catalog No. A18327
    Quick View
    EGFR 抑制剂
    RG14620 is an EGFR inhibitor with an IC50 of 3 μM. 了解更多
  9. MTX-211

    Catalog No. A18324
    Quick View
    EGFR/PI3K 双重抑制剂
    MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer. 了解更多
  10. DBPR112

    Catalog No. A18857
    Quick View
    EGFR 抑制剂
    DBPR112 is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. 了解更多
  11. EGFR-IN-7

    Catalog No. A18562
    Quick View
    EGFR 抑制剂
    EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, and shows anti-tumor activity. 了解更多
  12. Mutated EGFR-IN-2

    Catalog No. A18565
    Quick View
    EGFR 抑制剂
    Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=??1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity. 了解更多
  13. Genistein

    Catalog No. A10425
    Quick View
    EGFR inhibitor
    Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis. 了解更多
  14. NSC 228155

    Catalog No. A16638
    Quick View
    EGFR activator
    NSC 228155 is an activator of EGFR, binds to the extracellular region of EGFR and enhance tyrosine phosphorylation of EGFR. 了解更多
  15. Epertinib

    Catalog No. A13777
    Quick View
    EGFR/HER2/HER4 inhibitor
    Epertinib is a potent, oral, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  16. EGFR-IN-2

    Catalog No. A12628
    Quick View
    EGFR inhibitor
    EGFR-IN-2 is a a noncovalent, irreversible, mutant-selective second generation EGFR inhibitor. 了解更多
  17. CHMFL-EGFR-202

    Catalog No. A12524
    Quick View
    EGFR inhibitor
    CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. 了解更多
  18. EGFR-IN-3

    Catalog No. A15847
    Quick View
    EGFR inhibitor
    EGFR-IN-3 is an epidermal growth factor receptor (EGFR) inhibitor. 了解更多
  19. Canertinib dihydrochloride

    Catalog No. A11344
    Quick View
    EGFR inhibitor
    Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. 了解更多
  20. Afatinib

    Catalog No. A18014
    Quick View
    EGFR inhibitor
    Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. 了解更多
  21. Tarloxotinib bromide

    Catalog No. A20849
    Quick View
    EGFR/HER2 inhibitor
    Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor. 了解更多
  22. Mutant EGFR inhibitor

    Catalog No. A21144
    Quick View
    EGFR inhibitor
    Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多
  23. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  24. AST2818 mesylate

    Catalog No. A21666
    Quick View
    EGFR inhibitor
    AST2818 mesylate is an EGFR inhibitor. 了解更多
  25. Nazartinib mesylate

    Catalog No. A21741
    Quick View
    covalent mutant-selective EGFR inhibitor
    Nazartinib mesylate (EGF816 mesylate) is a novel, covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min?1 on EGFR(L858R/790M) mutant, respectively. 了解更多
  26. Nazartinib S-enantiomer

    Catalog No. A21747
    Quick View
    EGFR inhibitor
    Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. 了解更多
  27. Pyrotinib dimaleate

    Catalog No. A21756
    Quick View
    EGFR/HER2 dual inhibitor
    Pyrotinib dimaleate (SHR-1258 dimaleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50 s of 13 and 38 nM, respectively. 了解更多
  28. Epertinib hydrochloride

    Catalog No. A21950
    Quick View
    EGFR, HER2 and HER4 inhibitor
    Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  29. Lifirafenib

    Catalog No. A20988
    Quick View
    Raf/EGFR inhibitor
    Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多
  30. (-)-Epigallocatechin gallate

    Catalog No. A10005
    Quick View
    Antioxidant, antiangiogenic, antitumor agent
    (-)-Epigallocatechin gallate是一种从绿茶中分离出来的强效抗氧化剂多酚类黄酮。 了解更多
  31. Pelitinib (EKB-569)

    Catalog No. A10706
    Quick View
    EGFR 抑制剂
    Pelitinib (EKB-569)是一种有效的,不可逆EGFR抑制剂,IC50为38.5 nM 了解更多
  32. Neratinib (HKI-272)

    Catalog No. A10638
    Quick View
    HER2 抑制剂
    Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。 了解更多
  33. Canertinib (CI-1033)

    Catalog No. A10211
    Quick View
    HER2/ErbB2 抑制剂
    Canertinib (CI-1033)是一种不可逆的酪氨酸激酶抑制剂,对EGFR(IC50 0.8 nM),HER-2(IC50 19 nM)和ErbB-4(IC50 7 nM)具有活性。 了解更多
  34. BIBW2992 (Afatinib)

    Catalog No. A10141
    Quick View
    EGFR 抑制剂
    BIBW2992 (Afatinib)是酪氨酸激酶抑制剂(TKI),它不可逆地抑制人表皮生长因子受体2(Her2)和表皮生长因子受体(EGFR)激酶。 了解更多
  35. AZD8931 (Sapitinib)

    Catalog No. A10116
    Quick View
    pan-EGFR/pan-erbB 抑制剂
    AZD8931 (Sapitinib)是ErbB1,ErbB2和ErbB3受体信号传导的等效抑制剂。 了解更多
  36. WZ4002

    Catalog No. A10991
    Quick View
    EGFR 抑制剂
    WZ4002是一种新型的,突变选择性EGFR抑制剂,作用于EGFR(L858R)/(T790M),在BaF3细胞系中IC50为2 nM/8 nM;对ERBB2磷酸化(T798I)没有抑制作用。 了解更多
  37. Gefitinib (Iressa)

    Catalog No. A10422
    Quick View
    EGFR 抑制剂
    Gefitinib (Iressa)是一种EGFR抑制剂,可阻断靶细胞中表皮生长因子受体(EGFR)的信号传导。 了解更多
  38. Erlotinib HCl

    Catalog No. A10362
    Quick View
    EGFR 抑制剂
    Erlotinib hydrochloride是一种可逆的酪氨酸激酶抑制剂,作用于表皮生长因子受体(EGFR)。 了解更多
  39. Lapatinib Ditosylate

    Catalog No. A10514
    Quick View
    HER2 抑制剂
    Lapatinib是一种双重酪氨酸激酶抑制剂,可阻断HER2生长受体途径。 了解更多
  40. AG-1478 (Tyrphostin AG-1478)

    Catalog No. A11022
    Quick View
    EGFR 抑制剂
    AG-1478 (Tyrphostin AG-1478)是EGFR激酶的抑制剂,IC50值为3 nM。 了解更多
  41. OSI-420

    Catalog No. A10678
    Quick View
    EGFR 抑制剂
    OSI-420 (Desmethyl Erlotinib,CP-473420)是一种口服活性EGFR酪氨酸激酶抑制剂,可通过抑制细胞间结构域来抑制受体酪氨酸激酶(TKs)。 了解更多
  42. CUDC-101

    Catalog No. A10246
    Quick View
    HDAC 抑制剂
    CUDC-101是一种抑制多种靶标的新型化合物,旨在抑制HDAC,EGFR和Her2。 了解更多
  43. WZ8040

    Catalog No. A10992
    Quick View
    EGFR 抑制剂
    WZ8040是一种新型的EGFR抑制剂,可抑制含有EGFR-T790M的细胞系的生长并抑制EGFR磷酸化。 了解更多
  44. WZ3146

    Catalog No. A10990
    Quick View
    EGFR 抑制剂
    WZ3146是EGFR受体激酶突变体的抑制剂,该突变体在活性位点网守残基(T790M)中带有突变,并且对野生型EGFR激酶的效力要低得多。 了解更多
  45. PD153035 (HCl salt)

    Catalog No. A10702
    Quick View
    EGFR 抑制剂
    PD153035 (HCl salt)是EGFR酪氨酸激酶活性的极其有效和特异的抑制剂。 了解更多
  46. CP-724714

    Catalog No. A10242
    Quick View
    HER2/ErbB2 抑制剂
    CP-724714是一种有效的,选择性HER2/ErbB2抑制剂,可抑制HER2激酶(IC50 3.8 ng/ml)。 了解更多
  47. BMS 599626 (AC480)

    Catalog No. A11209
    Quick View
    EGFR 抑制剂
    BMS 599626 (AC480)是一种选择性的,高效效的HER1,HER2和HER4酪氨酸激酶抑制剂(IC50分别为22、32和190 nM),具有潜在的抗肿瘤活性。 了解更多
  48. Arry-380 analog

    Catalog No. A11027
    Quick View
    HER2 抑制剂
    Arry-380 analog是一种ErbB-2抑制剂,可选择性结合并抑制ErbB-2的磷酸化,从而导致表达ErbB-2的肿瘤细胞的生长抑制和死亡。 了解更多
  49. AV-412

    Catalog No. A11028
    Quick View
    EGFR 抑制剂
    AV-412是一种EGFR / HER2抑制剂,可与表皮生长因子受体(EGFR)和人表皮生长因子受体2(HER2)结合并抑制其生长,这可能会导致肿瘤生长和血管生成受到抑制。 了解更多

产品 1 到 50 共 106个

每页
页面:
  1. 1
  2. 2
  3. 3

设置降序顺序
Rewards